SpringerLink
Log in

Clinical significance of the expression levels of serum transforming growth factor-β and CXC type chemokine ligand 13 in primary Sjogren’s syndrome patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to investigate the expression levels of the serum transforming growth factor-β1 (TGF-β1) CXC type chemokine ligand 13 (CXCL13) in primary Sjogren’s syndrome (pSS) patients and its correlation with disease severity.

Method

Thirty patients with pSS admitted to Nan**g Traditional Chinese Medicine Affiliated Hospital of Nan**g University of Traditional Chinese Medicine from January 2021 to December 2022 were included as the pSS group, while 30 patients who underwent physical examination during the same period were included as the control group. The levels of TGF-β1 and CXCL13 were detected. The diagnostic value of TGF-β1 and CXCL13 for pSS was analyzed. Detection of serum TGF-β1 and CXCL13 levels in pSS patients with different disease activities and lip gland pathological grading of pSS was done. We compared the correlation between TGF-β1 and CXCL13 levels and disease activity and labial gland pathological grading in pSS patients.

Result

The TGF-β1 and CXCL13 levels in the pSS group were higher than those in the control group. The area under the receiver operating characteristic (ROC) curve (AUC) for TGF-β1 and CXCL13 diagnosis of pSS was 0.790 (95% confidence interval (CI): 0.720~0.861) and 0.838 (95% CI: 0.778~0.898), respectively. The serum TGF-β1 and CXCL13 levels of pSS patients significantly increase with the increase of disease activity and lip gland pathological grading. The TGF-β1 and CXCL13 levels in pSS patients were positively correlated with disease activity and lip gland pathological grading.

Conclusion

The levels of TGF-β1 and CXCL13 in pSS patients were increased, and it was closely related to disease activity and lip gland pathological grading, which can be used as an effective indicator for the diagnosis of pSS.

Key Points

• The TGF-β1 and CXCL13 levels in the pSS group were higher than those in the control group.

• The TGF-β1 and CXCL13 levels in pSS patients were positively correlated with disease activity and lip gland pathological grading.

• TGF-β1 and CXCL13 can be used as an effective indicator for the diagnosis of pSS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Tomiak C, Dorner T (2006) Sjogren’s syndrome. Current aspects from a rheumatological point of view. Z Rheumatol 65:505–517

    Article  CAS  PubMed  Google Scholar 

  2. Qin B, Wang J, Yang Z et al (2015) Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983–1989

    Article  CAS  PubMed  Google Scholar 

  3. Westhoff G, Zink A (2010) Epidemiology of primary Sjogren’s syndrome. Z Rheumatol 69:41–49

    Article  CAS  PubMed  Google Scholar 

  4. Margherita S, Roberto T, Domenico R et al (2020) IL-6 contributes to the TGF-β1-mediated epithelial to mesenchymal transition in human salivary gland epithelial cells. Arch Immunol Ther Exp 68(5):27

    Article  Google Scholar 

  5. Chung YL et al (2023) The wound-healing activity of PEDOT-PSS in animals. Int J Mol Sci 24(16):12539

    Article  CAS  PubMed  Google Scholar 

  6. Brito-Zeron P, Theander E, Baldini C et al (2016) Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 12:137–156

    Article  CAS  PubMed  Google Scholar 

  7. Fox PC, Bowman SJ, Segal B et al (2008) Oral involvement in primary Sjögren syndrome. J Am Dent Assoc 139:1592–1601

    Article  PubMed  Google Scholar 

  8. Bron AJ, Tomlinson A, Foulks GN et al (2014) Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf 12:1–31

    Article  Google Scholar 

  9. Villa A, Abati S (2011) Risk factors and symptoms associated with xerostomia: a cross-sectional study. Aust Dent J 56:290–295

    Article  CAS  PubMed  Google Scholar 

  10. Cornec D, Saraux A, Jousse-Joulin S et al (2015) The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review. Clin Rev Allergy Immunol 49:278–287

    Article  PubMed  Google Scholar 

  11. Ramos-Casals M, Brito-Zeron P, Solans R et al (2014) Systemic involvement in primary Sjögren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology (Oxford) 53:321–331

    Article  PubMed  Google Scholar 

  12. Nishishinya MB, Pereda CA, Munoz-Fernandez S et al (2015) Identification of lymphoma predictors in patients with primary Sjögren’s syndrome: a systematic literature review and meta-analysis. Rheumatol Int 35:17–26

    Article  CAS  PubMed  Google Scholar 

  13. Theander E, Vasaitis L, Baecklund E et al (2011) Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis 70:1363–1368

    Article  PubMed  Google Scholar 

  14. Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sjögren’s syndrome. Eur Respir Rev 25:110–123

    Article  PubMed Central  PubMed  Google Scholar 

  15. Evans R, Zdebik A, Ciurtin C, Walsh SB (2015) Renal involvement in primary Sjögren’s syndrome. Rheumatology (Oxford) 549:1541–1548

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology and Rheumatology, Nan**g Hospital of Chinese Medicine Affiliated to Nan**g University of Chinese Medicine, Nan**g, China

    **g He, Changsong Xu, Yamei Zhu, Meimei Xu, Yueyue Chen, Liang Guo, Zhengyue **g, Bo Xu & Suling Wu

Authors
  1. **g He
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Changsong Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yamei Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meimei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yueyue Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liang Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhengyue **g
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bo Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Suling Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suling Wu.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, J., Xu, C., Zhu, Y. et al. Clinical significance of the expression levels of serum transforming growth factor-β and CXC type chemokine ligand 13 in primary Sjogren’s syndrome patients. Clin Rheumatol 42, 3283–3288 (2023). https://doi.org/10.1007/s10067-023-06783-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06783-6

Keywords

Search

Navigation